⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
prnewswire.com
HTFL
IRTC
TEM
BFLY
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
businesswire.com
TEM
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
businesswire.com
TEM
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
businesswire.com
TEM
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
businesswire.com
TEM
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
businesswire.com
TEM
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
businesswire.com
TEM
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
businesswire.com
TEM
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
businesswire.com
TEM
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
businesswire.com
TEM